Top Markets
#1 DogBull DogBull +75.07%
#2 Siren Siren +31.73%
#3 Verus Coin Verus Coin +18.65%
#4 OriginTrail OriginTrail +14.62%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.73%
#6 Tutorial Tutorial +7.87%
#7 COTI COTI +7.71%
#8 Unit Pump Unit Pump +7.21%
#9 Pump.fun Pump.fun +7.21%
#10 PulseChain PulseChain +6.89%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Zhengye Biotechnology Holding Limited Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited

ZYBT
Rank in Stocks #22153
Zhengye Biotechnology Holding Limited specializes in the creation,... Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
Share Price
$1.97
Last synced: 2026-08-21
Market Cap
$93.43M
Change (1 day)
4.31%
Change (1 year)
-71.76%
Country
CN
Trade Zhengye Biotechnology Holding Limited (ZYBT)

Category

Healthcare
P/E ratio for Zhengye Biotechnology Holding Limited (ZYBT)
P/E ratio as of 2026 TTM: 0
According to Zhengye Biotechnology Holding Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Zhengye Biotechnology Holding Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.